In IPF patients on antifibrotic treatment, carriage of the MUC5B rs35705950 T allele, is associated with increased honeycombing over time, whereas non-carriers of the mutant allele experience increase of both ground glass opacity and honeycombing, despite a similar functional decline. This evidence concerns the gene MUC5B and idiopathic pulmonary fibrosis.